Jakob Mathiszig-Lee

Postoperative outcomes and costs associated with multimodal prehabilitation for advanced ovarian cancer surgery: an exploratory retrospective cohort study at a UK specialist centre

Neoadjuvant chemotherapy (NACT) followed by cytoreductive surgery (CRS) is the standard of care for advanced ovarian cancer and is associated with deconditioning and a high burden of perioperative morbidity. Multimodal prehabilitation may attenuate physiological decline during NA...